期刊
STRUCTURE
卷 29, 期 2, 页码 170-+出版社
CELL PRESS
DOI: 10.1016/j.str.2020.11.005
关键词
-
资金
- NIH/NIGMS [R01GM115825]
- ACS postdoctoral fellowship [126774-PF-14178-01-DMC]
- NIH/NIGMS Maximizing Investigators' Research Award (MIRA) [R35, 1R35GM138291]
In drug design, GPCR partial agonists can fine-tune receptor output levels, and NMR studies have revealed distinct structural differences between partial and full agonist complexes, indicating different structural rearrangements for different signaling pathways.
In drug design, G protein-coupled receptor (GPCR) partial agonists enable one to fine-tune receptor output between basal and maximal signaling levels. Here, we add to the structural basis for rationalizing and monitoring partial agonism. NMR spectroscopy of partial agonist complexes of the A(2A) adenosine receptor (A(2A)AR) revealed conformations of the P-I-F activation motif that are distinctly different from full agonist complexes. At the intracellular surface, different conformations of helix VI observed for partial and full agonist complexes manifest a correlation between the efficacy-related structural rearrangement of this activation motif and intracellular signaling to partner proteins. While comparisons of A(2A)AR in complexes with partial and full agonists with different methods showed close similarity of the global folds, this NMR study now reveals subtle but distinct local structural differences related to partial agonism.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据